We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Glargine did not reduce CV events more than standard care in patients with dysglycemia.
- Authors
Lader, Ellis
- Abstract
The article presents information on the review of the research on insulin glargine regarding the reduction of cardiovascular (CV) events in the dysglycemia patients. It mentions the use of Randomized controlled trials, 2x2 factorial trials, and controlled trial for the methodology involved, and mentions the results in the negative reductions in CV by the glargine, targeted to the fasting plasma glucose.
- Publication
Annals of Internal Medicine, 2012, Vol 157, Issue 6, pJC3-10
- ISSN
0003-4819
- Publication type
Academic Journal
- DOI
10.7326/0003-4819-157-6-201209180-02010